Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Gyre Therapeutics (GYRE) Receivables - Other (2023 - 2025)

Gyre Therapeutics (GYRE) has disclosed Receivables - Other for 6 consecutive years, with $200000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 95.97% to $200000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $200000.0 through Dec 2025, down 95.97% year-over-year, with the annual reading at $200000.0 for FY2025, 95.97% down from the prior year.
  • Receivables - Other for Q4 2025 was $200000.0 at Gyre Therapeutics, roughly flat from $200000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $5.0 million in Q4 2024, with the low at $200000.0 in Q2 2025.
  • Average Receivables - Other over 3 years is $1.1 million, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Receivables - Other skyrocketed 333.33% in 2024, then tumbled 95.97% in 2025.
  • Over 3 years, Receivables - Other stood at $1.3 million in 2023, then soared by 281.62% to $5.0 million in 2024, then crashed by 95.97% to $200000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $200000.0, $200000.0, and $200000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.